SoftBank Group (9984) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
15 Jan, 2026Executive summary
Net income for the first half of FY2024 exceeded ¥1,005.3 billion, a turnaround from a ¥1,408.7 billion loss a year earlier, driven by strong gains from Vision Fund, T-Mobile, and Arm's robust performance.
Net asset value remained high at ¥29 trillion as of September, supported by robust cash reserves and ongoing AI investment focus.
Arm delivered record revenue and operating income growth, exceeding guidance and showing resilience post-IPO, with technology adoption expanding across sectors.
Major investment gains were recorded from Alibaba and T-Mobile, though offset by significant derivative losses on Alibaba-related contracts.
Vision Fund 1 and 2 both showed improved performance, with Vision Fund 2 making major new AI investments, including $500 million in OpenAI.
Financial highlights
Net sales rose to ¥3,469.9 billion in H1 FY2024, up ¥242.9 billion year-over-year, with net income attributable to owners at ¥1,005.3 billion.
Investment gains reached ¥2,651.0 billion, up ¥3,614.6 billion year-over-year, mainly from Vision Fund and T-Mobile.
Quarterly investment gains exceeded ¥2 trillion, with Vision Fund contributing ¥567 billion and T-Mobile ¥387 billion.
Cash and cash equivalents at period end were ¥4,476.3 billion, with recent improvements pushing cash above ¥4 trillion.
Loan-to-value ratio improved to below 12.5%, indicating strong financial stability.
Outlook and guidance
Arm projects Q3 FY2024 revenue of $920–$970 million (+12–18% YoY) and full-year revenue of $3.8–$4.1 billion (+18–27% YoY).
Arm expects non-GAAP fully diluted EPS of $1.45–$1.65 for FY2024.
Management remains focused on AI investments and is prepared to capitalize on future opportunities as financial stability strengthens.
Latest events from SoftBank Group
- Net income soared 398.7% on investment gains and strategic AI expansion, led by OpenAI.9984
Q3 202612 Feb 2026 - A $3B joint venture launches to deploy advanced enterprise AI agents in Japan and beyond.9984
Partnership3 Feb 2026 - Net income surged to ¥636.2B on investment gains, Arm growth, and strong financial discipline.9984
Q3 20253 Feb 2026 - First profit in four years, fueled by record investment gains and major AI commitments.9984
Q4 20253 Feb 2026 - AI-powered precision medicine launches in Japan, targeting 1M annual genomic tests and data-driven care.9984
Status Update3 Feb 2026 - Shareholder value hit JPY 34T, Arm led growth, and all proposals passed amid an ASI vision.9984
AGM 20243 Feb 2026 - Record NAV, Arm's record revenue, and Vision Fund 1 gains highlight robust AI-driven results.9984
Q1 20252 Feb 2026 - AI-driven demand, advanced chip designs, and ecosystem partnerships fuel strong growth.9984
Investor Update1 Dec 2025 - Net income hit ¥421.8B, with record NAV and share price, led by Arm, Vision Fund, and OpenAI.9984
Q1 202623 Nov 2025